Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 51.61B | 54.08B | 55.89B | 50.95B | 39.76B | 36.01B |
Gross Profit | 10.34B | 11.20B | 11.92B | 9.43B | 7.25B | 5.48B |
EBITDA | 4.58B | 5.30B | 6.83B | 4.81B | 3.35B | 1.94B |
Net Income | 2.40B | 2.90B | 3.77B | 2.67B | 2.35B | -143.00M |
Balance Sheet | ||||||
Total Assets | 71.43B | 73.85B | 71.21B | 63.97B | 54.80B | 49.99B |
Cash, Cash Equivalents and Short-Term Investments | 9.89B | 8.76B | 8.49B | 7.09B | 7.35B | 7.50B |
Total Debt | 26.84B | 26.38B | 22.71B | 18.83B | 15.09B | 19.41B |
Total Liabilities | 50.34B | 51.00B | 48.99B | 43.36B | 38.38B | 41.28B |
Stockholders Equity | 20.49B | 22.20B | 21.61B | 20.05B | 15.92B | 8.22B |
Cash Flow | ||||||
Free Cash Flow | 1.36B | -321.00M | -920.00M | -1.66B | 1.02B | 3.23B |
Operating Cash Flow | 3.09B | 1.55B | 386.00M | -523.00M | 2.10B | 4.17B |
Investing Cash Flow | -2.11B | -2.55B | -2.08B | -4.17B | 4.26B | -2.35B |
Financing Cash Flow | -1.42B | 403.00M | 2.93B | 3.33B | -875.00M | -1.14B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | $8.72B | 13.67 | 15.52% | 1.46% | 0.41% | -3.90% | |
76 Outperform | $53.65B | 17.51 | 16.77% | 3.91% | -11.92% | -38.21% | |
68 Neutral | $35.01B | 13.35 | 10.75% | 4.72% | -6.36% | -32.39% | |
66 Neutral | $204.23B | 22.17 | 52.73% | 1.32% | -4.87% | -10.47% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
63 Neutral | $126.81B | 24.52 | 21.59% | 1.35% | -20.63% | -34.82% | |
56 Neutral | $13.61B | 16.56 | 10.79% | 2.30% | -21.70% | -57.68% |